Theralase Technologies Management
Management criteria checks 3/4
Theralase Technologies' CEO is Roger Dumoulin-White, appointed in May 2023, has a tenure of less than a year. directly owns 4.8% of the company’s shares, worth $1.35M. The average tenure of the management team and the board of directors is 13.7 years and 5.8 years respectively.
Key information
Roger Dumoulin-White
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | less than a year |
| CEO ownership | 4.8% |
| Management average tenure | 13.7yrs |
| Board average tenure | 5.8yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | -CA$5m |
| Sep 30 2023 | n/a | n/a | -CA$4m |
| Jun 30 2023 | n/a | n/a | -CA$5m |
| Mar 31 2023 | n/a | n/a | -CA$5m |
| Dec 31 2022 | n/a | n/a | -CA$5m |
| Sep 30 2022 | n/a | n/a | -CA$6m |
| Jun 30 2022 | n/a | n/a | -CA$5m |
| Mar 31 2022 | n/a | n/a | -CA$5m |
| Dec 31 2021 | n/a | n/a | -CA$4m |
| Sep 30 2021 | n/a | n/a | -CA$4m |
| Jun 30 2021 | n/a | n/a | -CA$4m |
| Mar 31 2021 | n/a | n/a | -CA$5m |
| Dec 31 2020 | n/a | n/a | -CA$6m |
| Sep 30 2020 | n/a | n/a | -CA$8m |
| Jun 30 2020 | n/a | n/a | -CA$8m |
| Mar 31 2020 | n/a | n/a | -CA$8m |
| Dec 31 2019 | n/a | n/a | -CA$7m |
| Sep 30 2019 | n/a | n/a | -CA$5m |
| Jun 30 2019 | n/a | n/a | -CA$4m |
| Mar 31 2019 | n/a | n/a | -CA$3m |
| Dec 31 2018 | CA$301k | CA$300k | -CA$3m |
| Sep 30 2018 | n/a | n/a | -CA$4m |
| Jun 30 2018 | n/a | n/a | -CA$5m |
| Mar 31 2018 | n/a | n/a | -CA$6m |
| Dec 31 2017 | CA$734k | CA$300k | -CA$6m |
Compensation vs Market: Insufficient data to establish whether Roger's total compensation is reasonable compared to companies of similar size in the US market.
Compensation vs Earnings: Roger's compensation has been consistent with company performance over the past year.
CEO
Roger Dumoulin-White
less than a year
Tenure
CA$300,804
Compensation
Mr. Roger John Dumoulin-White, B.Sc., P.Eng., Pro. Dir., is President, Chief Executive Officer and Director of Theralase Technologies Inc. from May 2023. He joined the Theralase Technologies Inc. in 2003....
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CFO & Director | 19.9yrs | CA$483.08k | 1.27% CA$ 355.3k | |
| Chief Scientific Officer & Director | 13.2yrs | CA$533.08k | 0.12% CA$ 35.0k | |
| President | less than a year | CA$300.80k | 4.8% CA$ 1.3m | |
| President of World Trade Division | 17.4yrs | no data | no data | |
| Equine Medical Consultant | 13.7yrs | no data | no data |
13.7yrs
Average Tenure
Experienced Management: TLTF.F's management team is seasoned and experienced (13.7 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CFO & Director | 4.8yrs | CA$483.08k | 1.27% CA$ 355.3k | |
| Chief Scientific Officer & Director | 5.8yrs | CA$533.08k | 0.12% CA$ 35.0k | |
| President | less than a year | CA$300.80k | 4.8% CA$ 1.3m | |
| Independent Director | 16.3yrs | CA$158.72k | 0.78% CA$ 218.8k | |
| Independent Chairman of the Board | 11.2yrs | CA$158.72k | 0.021% CA$ 6.0k | |
| Independent Director | 11.2yrs | CA$195.90k | 0.094% CA$ 26.2k | |
| Member of Medical & Scientific Advisory Board | 9.3yrs | no data | no data | |
| Member of Medical & Scientific Advisory Board | 1.3yrs | no data | no data | |
| Independent Director | less than a year | no data | no data |
5.8yrs
Average Tenure
Experienced Board: TLTF.F's board of directors are considered experienced (5.8 years average tenure).